Drug discovery still too often relies on expensive trial and error. Researchers from ICTER show there is another way—building ...

Background Persistent shockable rhythms (refractory to or recurring after three or more defibrillation attempts) are ...

In the search for new drugs, artificial intelligence in the form of diffusion models is being used in drug design. What ...

BACKGROUND: The World Health Organization recommends echocardiographic screening and secondary prophylaxis for rheumatic ...

Scientist and medical technology entrepreneur J. Craig Venter published the first bacterial genome ever decoded in 1995. The ...

Street medicine is rapidly expanding in the United States, but realizing its potential to improve health outcomes will ...

Reimagining clinical trial engagement through community partnership, pragmatic design, and artificial intelligence–enabled ...

Organizational Norms and Work Demand as Predictors of Employees’ Perceived Productivity: Evidence from Financial Institutions in Malaysia Employee productivity remains a central concern for ...

The border along Kericho and Kisumu counties has been a constant flashpoint of insecurity, arising from perennial ethnic conflict between the Kipsigis and Luo tribes. The primary objective of the ...

Objectives Lesbian, gay, bisexual and transgender (LGBT) individuals have faced marginalisation and discrimination despite ...

Understanding epidemiological and clinical study designs is key to producing reliable health evidence. From descriptive reports to randomized trials, each design has unique strengths and limitations.

Choosing between qualitative, quantitative, or mixed methods can shape the direction and success of your doctoral research. Understanding each approach’s strengths, limitations, and alignment with ...